Erratum in: Comparative efficacies of Calmare® therapy and transcutaneous electrical nerve stimulation in randomized peripheral neuropathy subjects with resting state fMRI monitoring...Bodily TA, Edvalson L, Peacock JB; Comparative efficacies of Calmare® therapy and transcutaneous electrical nerve stimulation in randomized peripheral neuropathy subjects with resting state fMRI monitoring. Journal of Pain Management. 2020;13(2): 149-166.

Scrambler therapy®, an innovative therapy based on artificial neurons, created specifically for the non-invasive treatment of chronic neuropathic and oncological pain. The only type of medical device using this technology, manufactured under license since 2008, has been registered by the FDA in all...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Pain Management Vol. 14; no. 1; pp. 75 - 80
Autor principal: Marineo, Giuseppe
Formato: corrected article pictorial Journal Article
Publicado: Nova Science Publishers, Inc. 2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=151947564&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 151947564
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        19395914
        903P
      jtl: Journal of Pain Management
      issn: 19395914
      maglogo: N
    pubinfo:
      dt: 2021
      vid: 14
      iid: 1
      pid: 1040
      pub: Nova Science Publishers, Inc.
      place: Hauppauge, New York
    artinfo:
      ui:
        151947564
        151947564
        151947564
        151947564
      ppf: 75
      ppct: 5
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Erratum in: Comparative efficacies of Calmare® therapy and transcutaneous electrical nerve stimulation in randomized peripheral neuropathy subjects with resting state fMRI monitoring...Bodily TA, Edvalson L, Peacock JB; Comparative efficacies of Calmare® therapy and transcutaneous electrical nerve stimulation in randomized peripheral neuropathy subjects with resting state fMRI monitoring. Journal of Pain Management. 2020;13(2): 149-166.
      aug:
        au: Marineo, Giuseppe
        affil: Delta Research and Development-University of Rome Tor Vergata, Rome, Italy
      sug:
        subj:
          Peripheral Nervous System Diseases Therapy
          Pain Management Methods
          Transcutaneous Electric Nerve Stimulation
          Magnetic Resonance Imaging Evaluation
          Monitoring, Physiologic
          Chronic Pain Therapy
          Cancer Pain Therapy
          Noninvasive Procedures
          United States Food and Drug Administration Standards
          Drug Approval Legislation and Jurisprudence
          Confusion
          Research Personnel
          World Wide Web
          Publication Bias
          Publication Components
          Bias (Research)
          Treatment Outcomes
          Content Validity
      ab: Scrambler therapy®, an innovative therapy based on artificial neurons, created specifically for the non-invasive treatment of chronic neuropathic and oncological pain. The only type of medical device using this technology, manufactured under license since 2008, has been registered by the FDA in all its different generations as Scrambler therapy®, but initially marketed in the US under the trade name of "Calmare®". All of the different generations of the Scrambler Therapy® device are built on the same license. As a result, all scientific publications and binding usage procedures referring to Scrambler therapy®, are automatically applied to the generation known as "Calmare®" as well. This dual naming of the same technology has in some cases created much confusion among independent researchers. In particular, almost all of the relevant scientific literature, and the official scientific information website, are available only with the search key "Scrambler therapy.' Those who did not have access to the necessary information on the correct use of the device and on the sources of bias in clinical trials, unintentionally published studies affected by methodological errors and procedures of use not compatible with those necessary to ensure the effectiveness of the treatment and the validity of the study. This is also the case of the article "Comparative efficacies of Calmare® therapy and transcutaneous electrical nerve stimulation in randomized peripheral neuropathy subjects with resting state fMRI monitoring". The purpose of this article is to provide the erratum to restore correct scientific and clinical information.
      pubtype: Academic Journal
      doctype:
        corrected article
        pictorial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N